APA (7th ed.) Citation

Li Y, Xie Y, Gong C, Zhao Y, Zhang J, Zhang S, . . . Wang B. (2020). Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press.

Chicago Style (17th ed.) Citation

Li Y, et al. Comparative Treatment Patterns and Outcomes of Fulvestrant Versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press, 2020.

MLA (9th ed.) Citation

Li Y, et al. Comparative Treatment Patterns and Outcomes of Fulvestrant Versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press, 2020.